Ayurcann Holdings Corp.

Ayurcann Holdings Corp.

AYURF
Ayurcann Holdings Corp.US flagOther OTC
0.00
USD
- -
- -
58,411.00Market Cap

Total Valuation

Ayurcann Holdings Corp. carries a market capitalization of 58,411.00, placing it among publicly traded companies globally. Its enterprise value stands at 7.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap58,411.00
Enterprise Value7.88M

Share Statistics

Ayurcann Holdings Corp. currently has 194.70M shares outstanding.

Shares Outstanding194.70M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.26, and the price-to-book ratio stands at -1.34.

PE RatioN/A
PS Ratio0.26
PB Ratio-1.34
P/TBV Ratio-1.55
P/FCF Ratio10.63
P/OCF Ratio11.62

Enterprise Valuation

EV / Sales0.25
EV / EBITDAN/A
EV / EBITN/A
EV / FCF5.75

Financial Position

Ayurcann Holdings Corp. maintains a current ratio of 0.61, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -16.46, indicating conservative leverage, while an interest coverage ratio of -4.12 demonstrates limited ability to service its debt obligations.

Current Ratio0.61
Quick Ratio0.37
Debt / Equity-16.46
Debt / EBITDA-0.26
Interest Coverage-4.12

Financial Efficiency

Return on Equity (ROE)-553.55
Return on Assets (ROA)-31.26
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.81

Stock Price Statistics

Ayurcann Holdings Corp.'s stock has declined approximately -98.55072% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Beta (5Y)N/A
52-Week Price Change-98.55072%
50-Day Moving Average0.00
200-Day Moving Average0.01
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Ayurcann Holdings Corp. generated 31.28M in revenue and converted that into -4.39M in net income, yielding earnings per share of -0.02. EBITDA reached -2.53M, while operating income came in at -3.43M.

Revenue31.28M
Gross Profit9.05M
Operating Income-3.43M
Pretax Income-4.39M
Net Income-4.39M
EBITDA-2.53M
EBIT-3.43M
Earnings Per Share (EPS)-0.02

Balance Sheet

Ayurcann Holdings Corp. holds 840,435.00 in cash and equivalents against 667,583.00 in total debt, resulting in a net debt position of -717,647.00. Total book value stands at -6.02M, with working capital of -5.88M providing operational flexibility.

Cash & Cash Equivalents840,435.00
Total Debt667,583.00
Net Debt-717,647.00
Equity (Book Value)-6.02M
Book Value Per Share-0.03
Working Capital-5.88M

Cash Flow

Ayurcann Holdings Corp. produced 692,853.00 in operating cash flow over the past twelve months. After subtracting -64,743.00 in capital expenditures, free cash flow totaled 628,110.00 - equivalent to 0.00 per share.

Operating Cash Flow692,853.00
Capital Expenditures-64,743.00
Free Cash Flow628,110.00
FCF Per Share0.00

Margins

Ayurcann Holdings Corp. operates with a gross margin of 28.92, reflecting its pricing power and cost economics. The operating margin of -10.97 and net profit margin of -14.03 provide insight into operational efficiency.

Gross Margin28.92
Operating Margin-10.97
Pretax Margin-14.03
Profit Margin-14.03
EBITDA Margin-8.09

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield8.46
FCF Yield9.41

Stock Splits

Ayurcann Holdings Corp.'s most recent stock split took place on October 4, 2021 with a 2:1 split ratio.

Last Split Date10/4/2021
Split Ratio2:1

Scores

Ayurcann Holdings Corp. posts an Altman Z-Score of -1.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-1.02